 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 10, 2021 GLOBE NEWSWIRE -- ORIC Pharmaceuticals, Inc. Nasdaq: ORIC, a clinical stage oncology company focused on developing treatments that address mechanisms of resistance in cancer, today announced four preclinical poster presentations at the 2021 American Association for Cancer Research AACR virtual annual meeting on April 10-15, 2021. 